Stay updated on MGL-3196 in NASH Patients: Clinical Trial
Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual study details with an access-denied message.SummaryDifference21%

- Check36 days agoChange DetectedRevision tag on the page changed from v3.6.5 to v3.6.6, indicating an update to the page metadata or formatting. This appears to be a maintenance update rather than a modification to study content or results.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a new page/component version. This reflects an internal update rather than a change to the study details or public information.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, signaling a minor update to the page's revision history.SummaryDifference0.0%

- Check79 days agoChange DetectedThe glossary term Steatotic Liver Disease has been added and the term Fatty Liver Disease removed. This aligns the page's terminology with current nomenclature.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a newer revision of the study page, with no apparent changes to the study details or patient information.SummaryDifference0.0%

Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.